Abeona Therapeutics (ABEO) Change in Acquisitions & Divestments (2018 - 2025)
Abeona Therapeutics has reported Change in Acquisitions & Divestments over the past 8 years, most recently at $98.1 million for Q2 2025.
- Quarterly results put Change in Acquisitions & Divestments at $98.1 million for Q2 2025, up 473.46% from a year ago — trailing twelve months through Dec 2025 was $152.4 million (up 26.76% YoY), and the annual figure for FY2025 was $152.4 million, up 26.76%.
- Change in Acquisitions & Divestments for Q2 2025 was $98.1 million at Abeona Therapeutics, up from $54.3 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for ABEO hit a ceiling of $98.1 million in Q2 2025 and a floor of $8.7 million in Q1 2022.
- Median Change in Acquisitions & Divestments over the past 5 years was $19.5 million (2021), compared with a mean of $26.0 million.
- Biggest five-year swings in Change in Acquisitions & Divestments: crashed 65.32% in 2022 and later skyrocketed 473.46% in 2025.
- Abeona Therapeutics' Change in Acquisitions & Divestments stood at $16.2 million in 2021, then crashed by 44.99% to $8.9 million in 2022, then surged by 67.46% to $15.0 million in 2023, then soared by 100.22% to $30.0 million in 2024, then soared by 227.41% to $98.1 million in 2025.
- The last three reported values for Change in Acquisitions & Divestments were $98.1 million (Q2 2025), $54.3 million (Q1 2025), and $30.0 million (Q4 2024) per Business Quant data.